TherapeuticsMD Inc
therapeuticsmd.comWhat Do They Do?
Licenses women's health drugs, including IMVEXXY and BIJUVA, and prescription prenatal vitamins to pharmaceutical companies for commercialization.
10-K for FY2025, filed Mar 30, 2026TherapeuticsMD was previously a women’s healthcare company with a mission of creating and commercializing innovative products to support…View ↗
On December 30, 2022, we changed our business to become a pharmaceutical royalty company, currently receiving royalties on products…View ↗
On December 30, 2022, we granted an exclusive license to commercialize IMVEXXY in the United States and its possessions and territories to…View ↗
Who Are Their Customers?
Mayne Pharma holds U.S. rights to commercialize the licensed products; Knight and Theramex hold licenses for IMVEXXY and BIJUVA in markets outside the U.S.
10-K for FY2025, filed Mar 30, 2026TherapeuticsMD was previously a women’s healthcare company with a mission of creating and commercializing innovative products to support…View ↗
In July 2018, we entered into a license and supply agreement (the “Knight License Agreement”) with Knight Therapeutics Inc. (“Knight”)…View ↗
In June 2019, we entered into an exclusive license and supply agreement (the “Theramex License Agreement”) with Theramex HQ UK Limited…View ↗
How Are They Changing?
Loading...
